You asked a CEO

Four weeks ago, we asked you what’s on your mind. Specifically, what would you like to “Ask a CEO?”  Frankly, we were heartened and surprised by your response. So as promised, this week’s Feature, which coincides with the first anniversary of biotuesdays.com’s launch, is a rundown of the questions and the answers we received. We [...]

Microbix cleared to sell Kinlytic

Health Canada has issued a drug identification number for Kinlytic, formerly known as urokinase, allowing Microbix Biosystems (TSX:MBX) to sell its clot-busting therapy in Canada and markets worldwide. In a statement, Toronto-based Microbix said it will now submit an application to Health Canada for approval of its recently acquired urokinase inventory and targets its release [...]